| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $123.8M | +2194.2% |
| Gross Profit | $43.6M | +934.6% |
| R&D Expense | $7.3M | +735.5% |
| SG&A Expense | $57.8M | +1362.5% |
| Operating Income | -$380.0M | -9520.7% |
| Interest Expense | $19.5M | — |
| Pre-tax Income | -$342.8M | — |
| Income Tax | -$2.4M | -999.0% |
| Net Income | -$341.0M | — |
| EPS (Basic) | -$3.19 | -7875.0% |
| EPS (Diluted) | -$3.19 | -7875.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $58.2M | +3064.3% |
| Accounts Receivable | $22.8M | +239.6% |
| Inventory | $2.9M | +2402.6% |
| Current Assets | $106.7M | — |
| Total Assets | $569.3M | +237.0% |
| Current Liabilities | $96.7M | +3684.5% |
| Long-term Debt | $120.5M | +426.8% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$62.8M | -2942.9% |
| Capital Expenditures | $3.7M | — |
| Investing Cash Flow | $743K | -88.8% |
| Financing Cash Flow | $135.9M | +2498.2% |
| Free Cash Flow | -$66.5M | -3123.2% |
| Total Liabilities |
| $235.5M |
| +9115.0% |
| Stockholders' Equity | $318.5M | +6269.3% |